Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 8
2008 4
2009 1
2010 8
2011 5
2012 2
2013 3
2014 4
2015 8
2016 10
2017 12
2018 9
2019 8
2020 12
2021 3
2022 7
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular side-effects of modern cancer therapy.
Minami M, Matsumoto S, Horiuchi H. Minami M, et al. Among authors: matsumoto s. Circ J. 2010 Sep;74(9):1779-86. doi: 10.1253/circj.cj-10-0632. Epub 2010 Aug 12. Circ J. 2010. PMID: 20716834 Free article. Review.
Inter-assay variability of next-generation sequencing-based gene panels.
Quy PN, Fukuyama K, Kanai M, Kou T, Kondo T, Yoshioka M, Matsubara J, Sakuma T, Minamiguchi S, Matsumoto S, Muto M. Quy PN, et al. Among authors: matsumoto s. BMC Med Genomics. 2022 Apr 15;15(1):86. doi: 10.1186/s12920-022-01230-y. BMC Med Genomics. 2022. PMID: 35428255 Free PMC article.
[Precision Medicine Provided by National Health Insurance].
Muto M, Kondo T, Matsubara J, Kanai M, Matsumoto S, Ashida K, Suga J, Mukai K. Muto M, et al. Among authors: matsumoto s. Gan To Kagaku Ryoho. 2020 Aug;47(8):1158-1163. Gan To Kagaku Ryoho. 2020. PMID: 32829347 Japanese.
Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced pancreatic cancer: prospective multicenter observational study.
Kondo T, Kanai M, Matsubara J, Yamaguchi D, Ura T, Kou T, Itani T, Nomura M, Funakoshi T, Yokoyama A, Doi K, Tamaoki M, Yoshimura M, Uza N, Yamada T, Masui T, Minamiguchi S, Matsumoto S, Ishikawa H, Muto M. Kondo T, et al. Among authors: matsumoto s. Med Oncol. 2023 Apr 11;40(5):144. doi: 10.1007/s12032-023-02011-y. Med Oncol. 2023. PMID: 37039943
Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity-modulated radiotherapy for resectable pancreatic cancer: A prospective, open-label, phase II study.
Masui T, Nagai K, Anazawa T, Kasai Y, Yogo A, Yoshimura M, Mizowaki T, Uza N, Fukuda A, Matsumoto S, Kanai M, Isoda H, Kawaguchi Y, Uemoto S, Hatano E. Masui T, et al. Among authors: matsumoto s. Cancer Med. 2023 Sep;12(18):18611-18621. doi: 10.1002/cam4.6470. Epub 2023 Aug 30. Cancer Med. 2023. PMID: 37649318 Free PMC article.
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
Kawabata R, Chin K, Takahari D, Hosaka H, Muto O, Shindo Y, Nagata N, Yabusaki H, Imamura H, Endo S, Kashiwada T, Nakamura M, Hihara J, Kobayashi M, Sagawa T, Saito S, Sato A, Yamada T, Okano N, Shimada K, Matsushima M, Kataoka M, Matsumoto S, Goto M, Kotaka M, Shiraishi T, Yamai H, Nagashima F, Ishizuka N, Yamaguchi K. Kawabata R, et al. Among authors: matsumoto s. Gastric Cancer. 2023 Nov;26(6):1020-1029. doi: 10.1007/s10120-023-01423-z. Epub 2023 Aug 23. Gastric Cancer. 2023. PMID: 37610558 Free PMC article. Clinical Trial.
96 results